Adaptive servo-ventilation: How does it fit into the treatment of central sleep apnoea syndrome? Expert opinions

Publication date: Available online 21 November 2015
Source:Revue des Maladies Respiratoires
Author(s): P. Priou, M.-P. d'Ortho, T. Damy, J.-M. Davy, F. Gagnadoux, T. Gentina, J.-C. Meurice, J.-L. Pepin, R. Tamisier, C. Philippe
The preliminary results of the SERVE-HF study have led to the release of safety information with subsequent contraindication to the use of adaptive servo-ventilation (ASV) for the treatment of central sleep apnoeas in patients with chronic symptomatic systolic heart failure with left ventricular ejection fraction (LVEF) ≤ 45%. The aim of this article is to review these results, and to provide more detailed arguments based on data from the literature advocating the continued use of ASV in different indications, including heart failure with preserved LVEF, complex sleep apnoea syndrome, opioid-induced central sleep apnea syndrome, idiopathic central SAS, and central SAS due to a stroke. Based on these findings, we propose to set up registers dedicated to patients in whom ASV has been stopped and in the context of the next setting up of ASV in these specific indications to ensure patient safety and allow reasoned decisions on the use of ASV.



from #Medicine via ola Kala on Inoreader http://ift.tt/1O9PKiV
via IFTTT